利用综合并发症指数重新审视ISGLS术后肝衰竭标准:一项国际大样本肝切除队列研究
该研究纳入12个国际中心2010至2020年接受大范围肝切除术的1646例成人患者,比较ISGLS、Balzan与Mullen三种术后肝衰竭定义对90天死亡率的预测能力。ISGLS标准预测90天死亡率最佳(AUC=0.72,敏感性69.4%);ISGLS A级与综合并发症指数>40及90天死亡率均无关联,B级和C级与综合并发症指数>40风险升高相关,C级与90天死亡率风险升高相关。
要点
- 1646例大范围肝切除患者中,ISGLS标准诊断术后肝衰竭444例(27.0%)。
- ISGLS标准预测90天死亡率最佳,AUC=0.72,敏感性69.4%。
- ISGLS A级与综合并发症指数>40及90天死亡率均无关联。
核心结论
- 在该国际大范围肝切除队列中,ISGLS A级与90天死亡率或高综合并发症指数均无关联,对当前将该组患者归类为具有临床意义的术后肝衰竭提出质疑。
研究设计与样本
- 国际多中心队列研究,纳入12个国际中心2010至2020年接受大范围肝切除术的成人患者1646例。
主要发现
- 1646例患者中,符合Balzan标准19例(1.1%),符合Mullen标准68例(4.1%),符合ISGLS标准444例(27.0%)。
- 三种定义中,ISGLS标准对90天死亡率预测最佳(AUC=0.72;敏感性69.4%)。
- ISGLS B级和C级患者综合并发症指数>40的风险升高(B级OR 4.0;95%CI:2.2-7.2;C级OR 137.0;95%CI:59.2-317.4)。
- ISGLS C级患者90天死亡率风险升高(OR 113.6;95%CI:55.6-232.1)。
- ISGLS A级与综合并发症指数>40及90天死亡率均无关联。
关键数值与推荐
- ISGLS术后肝衰竭定义:符合ISGLS标准者444例(27.0%)。
- Balzan定义(INR>1.7且胆红素>2.92mg/dL):符合者19例(1.1%)。
- Mullen定义(峰值胆红素>7mg/dL):符合者68例(4.1%)。
- ISGLS B级综合并发症指数>40的OR为4.0(95%CI:2.2-7.2),C级为137.0(95%CI:59.2-317.4)。
- ISGLS C级90天死亡率的OR为113.6(95%CI:55.6-232.1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare different criteria for post-hepatectomy liver failure (PHLF) and evaluate the association between International Study Group of Liver Surgery (ISGLS) PHLF and the Comprehensive Complication Index (CCI)" and 90-day mortality. SUMMARY OF BACKGROUND DATA: PHLF is a serious complication following hepatic resection. Multiple criteria have been developed to characterize PHLF. METHODS: Adults who underwent major hepatectomies at twelve international centers (2010-2020) were included. We identified patients who met criteria for PHLF based on three definitions: 1) ISGLS, 2) Balzan (INR > 1.7 and bilirubin > 2.92mg/dL) or 3) Mullen (peak bilirubin >7mg/dL). We compared the 90-day mortality and major morbidity predicted by each definition. We then used logistic regression to determine the odds of CCI>40 and 90-day mortality associated with ISGLS grades. RESULTS: Among 1646 included patients, 19 (1.1%) met Balzan, 68 (4.1%) met Mullen, and 444 (27.0%) met ISGLS criteria for PHLF. Of the three definitions, the ISGLS criteria best predicted 90-day mortality (AUC = 0.72; sensitivity 69.4%). Patients with ISGLS grades B&C were at increased odds of CCI > 40 (grade B OR 4.0; 95% CI: 2.2-7.2; grade C OR 137.0; 95% CI: 59.2-317.4). Patients with ISGLS grade C were at increased odds of 90-day mortality (OR 113.6; 95% CI: 55.6-232.1). Grade A was not associated with CCI> 40 or 90-day mortality. CONCLUSIONS: In this diverse international cohort of major hepatectomies, ISGLS grade A was not associated with 90-day mortality or high CCI, calling into question the current classification of patients in this group as having clinically significant PHLF.
引用
- Calthorpe L, Rashidian N, Cacciaguerra AB, et al. Using the Comprehensive Complication Index to Rethink the ISGLS Criteria for Post-hepatectomy Liver Failure in an International Cohort of Major Hepatectomies. Ann Surg. 2021. PMID: 34913896. doi:10.1097/SLA.0000000000005338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。